Clinical Trial Update: Gardasil Vaccination in Post Stem Cell Transplant Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on Gardasil vaccination in post stem cell transplant patients, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stem Cell Transplant-related Immunogenicity

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Gardasil Vaccine, Stem Cell Transplant | Phase 1 | Status: COMPLETED | Results posted: 2019-07-01